Alzheimer’s Disease · Amyotrophic Lateral Sclerosis (ALS) · Autism · ADHD · Schizophrenia · Stroke · Brain Tumors · Multiple Sclerosis · Parkinson’s Disease · Epilepsy and Seizures · Dyslexia · ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

(Science) A case report assessed the effect of continuous exposure to ofatumumab (Kesimpta) during pregnancy in a patient ...

Backed by a $1 million grant, researchers at Case Western Reserve University in Ohio will explore ways to keep astrocytes in ...

The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader ... and remain an important unmet ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

The following is a summary of “Assessing and tailoring predictive equations of VO2 max for women with multiple sclerosis with ...

(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...

Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue.

A common yet underdiagnosed sleep disorder contributes to the development of dementia among adults -; particularly women, a ...